| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EBIOM.2017.09.013 |
| P8608 | Fatcat ID | release_vh4uqh73rbbshovosw7h7fmkfy |
| P932 | PMC publication ID | 5652021 |
| P698 | PubMed publication ID | 28943228 |
| P50 | author | John Thompson | Q47546533 |
| Kristin Wickens | Q93087415 | ||
| Robyn M Maude | Q79437815 | ||
| Rinki Murphy | Q87982767 | ||
| Rebecca Slykerman | Q91658995 | ||
| Julian Crane | Q109339423 | ||
| Edwin Mitchell | Q47546531 | ||
| P2093 | author name string | J Kang | |
| P Stone | |||
| T Stanley | |||
| G Purdie | |||
| C Barthow | |||
| J Rowden | |||
| F Hood | |||
| P Abels | |||
| Probiotic in Pregnancy Study Group | |||
| P2860 | cites work | Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry | Q22001357 |
| A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome | Q27499182 | ||
| Mood by microbe: towards clinical translation | Q28078701 | ||
| Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial | Q48067718 | ||
| Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial | Q48085534 | ||
| Health-related quality of life in postpartum depressed women | Q48529177 | ||
| Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers. | Q50263904 | ||
| A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial | Q50622653 | ||
| Major depressive disorder: probiotics may be an adjuvant therapy | Q81195261 | ||
| A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years | Q84387158 | ||
| Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 | ||
| Gut microbes and the brain: paradigm shift in neuroscience | Q28251501 | ||
| The impact of gut microbiota on brain and behaviour: implications for psychiatry | Q28267373 | ||
| The role of microbiome in central nervous system disorders | Q28304749 | ||
| Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve | Q29616854 | ||
| The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems | Q30415125 | ||
| Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis | Q33212249 | ||
| Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale | Q34186484 | ||
| The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). | Q34252950 | ||
| Systematic review of evidence to support the theory of psychobiotics | Q34494108 | ||
| Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals | Q34681064 | ||
| Perinatal antidepressant use: understanding women's preferences and concerns | Q34775567 | ||
| The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications | Q34813247 | ||
| The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. | Q35589120 | ||
| Mental disorders among adults with asthma: results from the World Mental Health Survey | Q35880430 | ||
| Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study | Q35929170 | ||
| Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials | Q36012463 | ||
| The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy | Q36038452 | ||
| Microbiome-Gut-Brain Axis: Probiotics and Their Association With Depression | Q36107604 | ||
| A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). | Q36264124 | ||
| Infants of depressed mothers | Q37448380 | ||
| The effects of probiotics on depressive symptoms in humans: a systematic review | Q37655518 | ||
| A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults | Q38160311 | ||
| Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial | Q38428190 | ||
| Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats | Q38685484 | ||
| A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression | Q38772776 | ||
| Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects | Q38793239 | ||
| The Importance of Diet and Gut Health to the Treatment and Prevention of Mental Disorders | Q38802960 | ||
| Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression | Q42942477 | ||
| Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? | Q44138178 | ||
| Gut microbes in correlation with mood: case study in a closed experimental human life support system. | Q46571807 | ||
| Postnatal depressive symptoms among Pacific mothers in Auckland: prevalence and risk factors | Q47223874 | ||
| Postnatal depression in a community cohort | Q47236271 | ||
| P921 | main subject | placebo | Q269829 |
| postpartum period | Q749115 | ||
| Lactobacillus rhamnosus | Q1607640 | ||
| P304 | page(s) | 159-165 | |
| P577 | publication date | 2017-09-14 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial | |
| P478 | volume | 24 |
| Q55110638 | "Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders. |
| Q93077579 | A potential role for the gut microbiome in substance use disorders |
| Q58586863 | Antidepressant Effects of Rosemary Extracts Associate With Anti-inflammatory Effect and Rebalance of Gut Microbiota |
| Q89493771 | Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential |
| Q93339716 | Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes |
| Q90043445 | Current Perspectives on Gut Microbiome Dysbiosis and Depression |
| Q64266366 | Disentangling What We Know About Microbes and Mental Health |
| Q55000093 | Dysbiotic drift and biopsychosocial medicine: how the microbiome links personal, public and planetary health. |
| Q98290814 | Effect of heat-inactivated Lactobacillus paracasei N1115 on microbiota and gut-brain axis related molecules |
| Q64883335 | Effects of Lactobacillus plantarum PS128 on Children with Autism Spectrum Disorder in Taiwan: A Randomized, Double-Blind, Placebo-Controlled Trial. |
| Q88883052 | Emerging literature in the Microbiota-Brain Axis and Perinatal Mood and Anxiety Disorders |
| Q92260673 | Food 4 Health - He Oranga Kai: Assessing the efficacy, acceptability and economic implications of Lactobacillus rhamnosus HN001 and β-glucan to improve glycated haemoglobin, metabolic health, and general well-being in adults with pre-diabetes: study |
| Q64096081 | Forty-five-year evolution of probiotic therapy |
| Q92106368 | Gut Microbiome and Modulation of CNS Function |
| Q92332225 | Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health |
| Q92495254 | Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder |
| Q89537257 | Healthy Eating, Physical Activity, and Sleep Hygiene (HEPAS) as the Winning Triad for Sustaining Physical and Mental Health in Patients at Risk for or with Neuropsychiatric Disorders: Considerations for Clinical Practice |
| Q60935997 | Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties |
| Q104690816 | Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study) |
| Q93097689 | Maternal separation in rodents: a journey from gut to brain and nutritional perspectives |
| Q90079839 | Modulation of the intestinal microbiota and the metabolites produced by the administration of ice cream and a dietary supplement containing the same probiotics |
| Q58760977 | Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling |
| Q59807082 | Occurrence and Dynamism of Lactic Acid Bacteria in Distinct Ecological Niches: A Multifaceted Functional Health Perspective |
| Q98200229 | Perinatal Depression: Heterogeneity of Disease and in Animal Models |
| Q90029576 | Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials |
| Q93109023 | Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation |
| Q89741613 | Precision medicine in perinatal depression in light of the human microbiome |
| Q49907257 | Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression |
| Q93012819 | Probiotics and Maternal Mental Health: A Randomised Controlled Trial among Pregnant Women with Obesity |
| Q64910852 | Probiotics in Extraintestinal Diseases: Current Trends and New Directions. |
| Q91964932 | Probiotics in pregnancy: protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial) |
| Q91637380 | Prophylactic Effects of Bifidobacterium adolescentis on Anxiety and Depression-Like Phenotypes After Chronic Stress: A Role of the Gut Microbiota-Inflammation Axis |
| Q42651365 | Quo Vadis, Probiotics? Human Research Supports Further Study of Beneficial Microbes in Mental Health |
| Q57475754 | Resilience priming: Translational models for understanding resiliency and adaptation to early life adversity |
| Q48091484 | Searching for the gut microbial contributing factors to social behavior in rodent models |
| Q57186276 | The Gut-Brain Axis and the Microbiome: Mechanisms and Clinical Implications |
| Q93060202 | The Preventive and Curative Effects of Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 on Immobilization Stress-Induced Anxiety/Depression and Colitis in Mice |
| Q55490879 | The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature. |
| Q91580929 | The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? |
| Q91723987 | You've got male: Sex and the microbiota-gut-brain axis across the lifespan |
Search more.